Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,038,696
-
Share change
-
+303,015
-
Total reported value
-
$2,068,637
-
Price per share
-
$1.99
-
Number of holders
-
14
-
Value change
-
+$521,581
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of AKERS BIOSCIENCES INC - COM as of Q4 2020
As of 31 Dec 2020,
AKERS BIOSCIENCES INC - COM was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,038,696 shares.
The largest 10 holders included
NorthRock Partners, LLC, Shay Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Candriam Luxembourg S.C.A., SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, We Are One Seven, LLC, Private Advisor Group, LLC, and INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.